Candesartan Cilexetil
Candesartan Cilexetil is a pharmaceutical drug with 30 clinical trials. Historical success rate of 96.0%.
Success Metrics
Based on 24 completed trials
Phase Distribution
Phase Distribution
5
Early Stage
6
Mid Stage
16
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
92.3%
24 of 26 finished
7.7%
2 ended early
0
trials recruiting
30
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Multi-Arm Multi-Stage Adaptive Platform Trial (APT) for the Acute Treatment of Traumatic Brain Injury
Controlled Trial of Angiotensin Receptor Blocker (ARB) & Chemokine Receptor Type 2 (CCR2) Antagonist for the Treatment of COVID-19
Evaluate Efficacy and Safety of Ezetimibe/Rosuvastatin and Candesartan Cilexetil/Amlodipine Besylate Combination Tablets
Candesartan Cilexetil Special Drug Use Surveillance 「Challenge - Quality Control」
A Phase 2 Dose-finding Study of TAK-272 in Participants With Type 2 Diabetes Mellitus and Microalbuminuria
Clinical Trials (30)
Multi-Arm Multi-Stage Adaptive Platform Trial (APT) for the Acute Treatment of Traumatic Brain Injury
Controlled Trial of Angiotensin Receptor Blocker (ARB) & Chemokine Receptor Type 2 (CCR2) Antagonist for the Treatment of COVID-19
Evaluate Efficacy and Safety of Ezetimibe/Rosuvastatin and Candesartan Cilexetil/Amlodipine Besylate Combination Tablets
Candesartan Cilexetil Special Drug Use Surveillance 「Challenge - Quality Control」
A Phase 2 Dose-finding Study of TAK-272 in Participants With Type 2 Diabetes Mellitus and Microalbuminuria
Renal Response to Lower Body Negative Pressure in Pre-hypertensive States
Monotherapy-Controlled Study of Nifedipine Gastrointestinal Therapeutic System and Candesartan Cilexetil in Combination in Subjects With Essential Hypertension Inadequately Controlled on Candesartan Cilexetil
Efficacy and Safety of a Therapy Change From Candesartan 32 mg to Fixed Combination of Olmesartan 40 mg/Amlodipine 10 mg
Blopress Tablets Specified Drug-use Survey "Hypertension: Survey on Patients With Metabolic Syndrome"
DP-R208 Pharmacokinetic Study
Sevicontrol-1: Efficacy and Safety of a Fixed Combination of Olmesartan/ Amlodipine
Clinical Trial to Compare the Pharmacokinetics of DP-R208
Investigate a Interaction of Candesartan and Atorvastatin in Healthy Male Sugjects
Diabetic Retinopathy Candesartan Trials
Prophylactic Treatment of Episodic Cluster Headache
Impact of Diabetes on Left Ventricular Remodeling
The Clinical Study to Evaluate the Efficacy and Safety of Fimasartan in Patients With Mild to Moderate Essential Hypertension
ARIA (Atacand Renoprotection In NephropAthy Pt.)
Study to Characterize the Long-term Clinical Experience of Atacand in Hypertensive Children Ages 1 to<11 Years (Hypertension in Pediatrics)
Scandinavian Candesartan Acute Stroke Trial (SCAST)
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 30